AGC Pharma Chemicals Europe, S.L.U.
AGC Pharma Chemicals Europe, S.L.U., headquartered in Spain, is a prominent player in the pharmaceutical and chemical manufacturing industry. Established in the early 2000s, the company has rapidly expanded its operations across Europe, focusing on the production of high-quality active pharmaceutical ingredients (APIs) and intermediates. With a commitment to innovation and sustainability, AGC Pharma Chemicals offers a diverse range of services, including custom synthesis and contract manufacturing, tailored to meet the specific needs of its clients. The company is recognised for its stringent quality control measures and adherence to regulatory standards, positioning it as a trusted partner in the pharmaceutical supply chain. AGC Pharma Chemicals has achieved significant milestones, including certifications that underscore its dedication to excellence, making it a key player in the competitive landscape of pharmaceutical chemicals.
DitchCarbon Score
How does AGC Pharma Chemicals Europe, S.L.U.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
AGC Pharma Chemicals Europe, S.L.U.'s score of 13 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
AGC Pharma Chemicals Europe, S.L.U.'s reported carbon emissions
In 2023, AGC Pharma Chemicals Europe, S.L.U. reported total carbon emissions of approximately 19,470,000 kg CO2e from Scope 1 and Scope 3 sources. The Scope 1 emissions alone accounted for about 1,947,000 kg CO2e, while Scope 3 emissions were significantly higher at approximately 17,810,000 kg CO2e. Over the previous years, the company has shown a trend of fluctuating emissions. In 2022, total emissions were around 22,192,000 kg CO2e, with Scope 1 emissions at about 1,582,000 kg CO2e. In 2021, emissions peaked at approximately 49,071,000 kg CO2e, with Scope 1 emissions of about 1,546,000 kg CO2e. This indicates a notable reduction in total emissions from 2021 to 2023. AGC Pharma Chemicals has not publicly committed to specific reduction targets or initiatives, as there are no documented reduction targets or climate pledges available. The absence of Scope 2 emissions in their reports suggests a focus on direct emissions and those from their supply chain. The company continues to monitor and report its emissions, aligning with industry standards for transparency in climate impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 2,056,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | - | - | - | - | - |
| Scope 3 | - | - | 00,000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
AGC Pharma Chemicals Europe, S.L.U. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
